The Cancer Drug Development Forum – CDDF is the platform for all stakeholders involved in the development of cancer drugs.

CDDF Community

 

 

Become part of the CDDF community working together to find ways to accelerate oncology drug development and deliver optimal treatment to cancer patients

 

CDDF has developed a community of stakeholders who support our shared mission to facilitate debate and progress in the field of oncology drug development. Non-commercial organisations (academia, NGOs and associations), pharmaceutical companies, regulatory agencies and individuals in the community of cancer research can join the CDDF network and collaborate with us. The CDDF believes that collaboration is key to overcome challenges in the development of cancer drugs. By establishing a multi-stakeholder network and working together constructively we can achieve our goal to increase efficiency in cancer drug development and accelerate the delivery of effective oncology treatment to patients.

We thank CDDF members and the following partners for their continuing support.

REGULATORY AUTHORITIES

CDDF collaborates with representatives from regulatory authorities to obtain their views on drug development.

PHARMACEUTICAL INDUSTRY PARTNERS

CDDF pharmaceutical industry partners provide the industry perspective on challenges to be addressed in cancer drug development.

ORGANISATIONS

CDDF has established close cooperation with the following organizations whose missions are in line with CDDF’s.

PATIENT ADVOCACY GROUPS

CDDF works closely with patient advocacy groups to incorporate the patient perspective into our discussion.

Cancer Drug Development Forum asbl
Registered office: c/o BLSI, Clos Chapelle-aux-Champs 30, 1200 Woluwe Saint Lambert, Belgium
Register of legal entities: the French Speaking Enterprise Court in Brussels
Enterprise number: 738.523.752

info@cddf.org
Tel: +32 2 880 62 70